Cepheid, Others Look Beyond Respiratory Infections in the Molecular POC Diagnostics Market

Companies looking beyond the clinical lab in the molecular diagnostics market predominately target rapid test demand in primary care and critical care, chiefly respiratory infections. All CLIA waivers to date for molecular tests have been for respiratory infections (influenza, strep A, RSV), though equally ample and more promising markets for molecular point-of-care (POC) diagnostics market will be found in other areas - including women’s health/sexual health and high-burden diseases in the deve...


Leading Infectious Diseases in the IVD Market - Women’s Health and Sexually Transmitted Infections

Leading Infectious Diseases in the IVD Market - Women’s Health and Sexually Transmitted Infections

The following analysis is derived from Kalorama Information’s recently released global market research report: The Worldwide Market for Infectious Disease Diagnostic Tests. A more comprehensive report on assorted women’s health diagnostics, including non-infectious disease tests, is available with Diagnostic Markets for Women’s Health (Pregnancy and Ovulation, Bone Density, Prenatal Screening, Ultrasound, Mammography, Pap Smear, Colposcopy, HPV, UTI and Other Testing).

This is the fourth in a ...


Rising Diagnostics Standards Drive Growth in Women’s Health Market

Rising Diagnostics Standards Drive Growth in Women’s Health Market

Once limited to obstetrics and gynecology, women’s health now encompasses the fields of urology, maternal-fetal medicine, oncology, and even autoimmune diseases such as cystic fibrosis. In recent years, specialty diagnostics have in part driven exceptional growth in women’s health compared to the overall markets for in vivo (medical imaging) and in vitro (lab testing) diagnostics. Continued penetration and standardization of several diagnostic procedures are expected to lead market growth for wo...